[Sponsored] In an interview, Abarca Chief Information Officer Serge Perras discussed how Abarca is implementing AI and where he sees the most value for PBMs. The post AI Is at the Heart of PBM Evolution appeared first on MedCity News.
EKALAKA, Mont. — There was no doctor on-site when a patient arrived in early June at the emergency room in the small hospital at the intersection of two dirt roads in this town of 400 residents. There never is. Dahl Memorial’s three-bed emergency department — a two-hour drive from the closest hospital with more advanced…
People thinking about starting a business or retiring early — before they’re old enough for Medicare — may want to wait until November, when they can see just how much their Affordable Care Act health insurance will cost next year. Sharp increases are expected. Premiums for ACA health plans, also known as Obamacare, which many…
Mount Sinai researchers found that popular AI chatbots like ChatGPT and DeepSeek R1 can generate convincing but false medical information when given even a single fabricated term in a prompt. While the study underscored the need for stronger safeguards, its lead author noted that generative AI still holds major promise for reducing clinician workload if…
Navitus Health Solutions is launching a cost-plus pricing model through Costco Pharmacy. It will become available for clients starting in January for prescriptions filled at retail and mail order locations. The post Navitus, Costco Pharmacy Team Up for Cost-Plus Pricing Model appeared first on MedCity News.
By MATTHEW HOLT I moved over something I wrote on linkedin, so that it doesn’t vanish. I do this type of thing so you don’t have to & to make Brett Jansen happy I am writing in one line paragraphs. My question, is how doo LabCorp, Brown & Toland and Blue Shield Of California come…
Se suponía que iba a ser más fácil. Cuando la Ley de Cuidado de Salud a Bajo Precio (ACA) se aprobó en marzo de 2010, el objetivo era ayudar a que más personas en el país obtuvieran seguro médico. Y, de hecho, la creación de mercados en línea y la ampliación de los criterios de…
This tracker provides an overview of state laws/policies restricting minor access to gender affirming care and any associated litigation by state, identifying which groups of people are impacted in addition to minors, the types of penalties providers face, the status of legal challenges, and other key information.
Boehringer-Ingelheim pill Hernexeos was awarded accelerated FDA approval for advanced cases of non-small cell lung cancer with HER2 mutations. But Bayer is on its heels with an oral small molecule currently under FDA review in the same indication. The post FDA Nod Makes Boehringer Ingelheim Drug an Alternative to AstraZeneca ADC in Lung Cancer appeared…
A new analysis shows that individuals with employer insurance could save 41% on their out-of-pocket spending for asthma and COPD inhalers through manufacturer savings. In response to a U.S. Senate investigation into inhaler costs, 3 drug makers voluntarily capped out-of-pocket costs on their brand-name asthma and COPD inhalers.